US regulators delayed their decision on whether to approve the first pill taken on demand for a rare, inherited swelling disorder due to a “heavy workload and limited resources,” a biotech company said.
www.bloomberg.com
#FDA #Tells #Drugmaker #Heavy #Workload #Delay #Approval #Decision
FDA Tells Drugmaker ‘Heavy Workload’ to Delay Approval Decision
